Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00377715
What this trial is testing

Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 183
Early research (Phase 1)Study completedNCT03113812
What this trial is testing

Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Araclon Biotech S.L. 24
Testing effectiveness (Phase 2)Study completedNCT00348192
What this trial is testing

SB-742457 And Donepezil In Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06881836
What this trial is testing

ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ono Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT00325728
What this trial is testing

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Chronic Insomnia
Takeda 74
Not applicableNot Yet RecruitingNCT07841808
What this trial is testing

Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System) in Mild to Moderate AD Patients

Who this might be right for
Alzheimer s Disease
Sinaptica Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT01117948
What this trial is testing

Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.

Who this might be right for
Alzheimer´s Disease
JSW Lifesciences 219
Large-scale testing (Phase 3)Not Yet RecruitingNCT05303701
What this trial is testing

GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)

Who this might be right for
Moderate to Severe Alzheimer's Disease
Samsung Pharmaceutical Co., Ltd. 750
Testing effectiveness (Phase 2)Ended earlyNCT05670912
What this trial is testing

Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Capital Medical University 105
Testing effectiveness (Phase 2)Study completedNCT01343966
What this trial is testing

Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 448
Early research (Phase 1)Study completedNCT04566003
What this trial is testing

Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Genentech, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT01696123
What this trial is testing

Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine

Who this might be right for
Alzheimer Disease
Shahid Beheshti University of Medical Sciences 125
Early research (Phase 1)Study completedNCT02820896
What this trial is testing

RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT01436045
What this trial is testing

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Who this might be right for
Alzheimer's Disease
HealthPartners Institute 12
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00749216
What this trial is testing

Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 33
Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Not applicableAvailableNCT03539380
What this trial is testing

TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
TauRx Therapeutics Ltd
Testing effectiveness (Phase 2)Study completedNCT04251182
What this trial is testing

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

Who this might be right for
Alzheimer Disease
T3D Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Study completedNCT03001557
What this trial is testing

Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia

Who this might be right for
Irregular Sleep-Wake Rhythm Disorder
Eisai Inc. 63
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation